Top Genomics Startups in 2024

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.

Mendel’s confounders are a physician and a computer scientist. Each dreamed of building a “Jarvis” for medicine since they were 15 years old. Mendel envisions a future where machines learn from all patients and power better decisions across the entire spectrum of healthcare.

Semaphore Solutions is a Canadian software company that supports the software engineering needs of clinical genomics laboratories across Europe and North America. Our clients are cutting-edge laboratories using next-generation sequencing (NGS) technologies to provide critical medical services, customer-direct services, and research. Labbit is the brainchild of Semaphore. We’re a team of 65 informatics experts with a long history of supporting laboratories with LIMS implementation, customization and custom software. We aim to advance global health by enabling the rapid implementation and iteration of innovative diagnostics and therapies. We do this with Labbit, the next-generation LIMS that lets you accelerate innovation cycles and scale faster.

PetaGene provides transparent genomic compression, making clinical diagnostics speedier and more affordable, and enabling researchers across the world to move faster and store more of their sequenced data than ever before. Genetic Sequencing is poised to become a routine part of clinical diagnostics, with many leading hospitals already adopting Precision Medicine initiatives. As the cost of whole genome sequencing has fallen from $300 mil in 2003 to about $600 today, it has unleashed a flood of genomic data, making IT challenges a critical pain point for adoption. PetaGene empowers leading biopharma, academic and other researchers in their ability to investigate cancer, rare diseases and develop early warning diagnostics. petagene.com/wp-content/uploads/2017/10/PetaSuite-datasheet.pdf

Genetico aims to reduce time to diagnosis and enable new medical discovering in the field of rare and genetic diseases. We are building a clinical genetics workflow software with decision support capabilities aimed at assisting medical geneticists and other stakeholders engaged in the diagnosis and research of rare and genetic diseases. Rare diseases patients on an average wait up to 5-7 years in countries like US and UK to get accurate diagnosis. The problem is even more significant in countries like India with nascent technological infrastructure and awareness to deal with complex genetic conditions. Our efforts are currently focussed on Indian market but have strong global market potential. Customers: Genetic clinics, hospitals, molecular diagnostic labs, clinical research groups and other stakeholders engages in diagnosis and research of rare and genetic diseases. linkedin.com/pulse/rare-disease-indianew-approach-old-problems-arjun-gupta

We are a team of doctors, nurses and technologist, transforming healthcare using our ex-big Corp/large system expertise now with a startup. We are helping to break the silo's of healthcare, working around the broken system to help the elderly and chronic condition while improving quality of life and reducing cost of healthcare. RaDcareconnect: Digital health tools (telehealth enablement for doctor offices, ACO, nursing homes..etc), this is turning into a virtual health center/ Uber for telehealth, Remote Patient Monitoring -> reimbursement being captures, per month, per patient on recurrent basis, Big Data Analytics: Population Health, Informatics, helps providers, employers, payors. Special focus on improving quality of life for people living with Chronic Conditions and Elderly trying to live independently rather than ending up in nursing homes and reduce hospitalizations. **CoVID turbocharged our first line of business where we are already established in an area many are scrambling to figure out. With supply chain realignment towards Blockchain based, aligning with second line of business....our growth trajectory shifted in a positive manner. We are also able to help and be in the midst of this Pandemic. Blockchain in Healthcare Consortium: Created at the request of healthcare finance leaders in NY Metro area, who asked Globex Health founder who is an expert in healthcare finance to adapt the fintech blockchain to solve friction in healthcare that they face. Reduces overall cost of care, focus on payments/insurance, underwriting...(stealth mode, due to privacy concerns, contact directly for more info) Research Enablement: Collaborate to bring out research and solutions in the area of biotech, chronic disease cure (not just medicines that maintain), CRISPR, genomics (head of research is a 3 board certified MD with genomics